Syncytin-A Knockout Induces Placental Developmental Abnormalities Partially through Calpain1-Apoptos

来源 :生殖与发育医学(英文) | 被引量 : 0次 | 上传用户:coniji
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective::Structural abnormalities and dysfunction of the placenta contribute to pregnancy-related complications, such as preeclampsia. Syncytin-A (synA) has been reported to be expressed in the placenta. The contribution of synA to developmental abnormalities and dysfunction of the placenta remains elusive. In this study, we aimed to explore the role of synA in placental development and functions.Methods::SynA-knockout mice were generated using the CRISPR-Cas9 method, and the phenotypes of the placenta and fetus of n synA-knockout mice were observed. Real-time quantitative polymerase chain reaction (PCR) and routine PCR were employed to detect the genotypes of the offspring. CD31 immunohistochemistry was used to evaluate the vessel density of the placenta, and the protein levels of key molecules were measured by western blotting.n Results::SynA knockout caused fetal death. Furthermore, n synA-knockout mice showed placental developmental abnormalities, indicated by a thinner labyrinth layer, thicker spongiotrophoblast layer, lower blood vessel density, and significantly higher numbers of apoptotic trophoblasts, when compared with wild-type littermates. Mechanistically, n synA ablation induced apoptosis-inducing factor (AIF) cleavage and nuclear localization and promoted placental trophoblast apoptosis. In addition, n synA knockout increased the calpain1 protein levels. The calpain1 inhibitor calpeptin blocked n synA knockout-induced AIF cleavage, partially restoring the placental structural abnormalities of n synA-knockout mice.n Conclusions::SynA knockout leads to placental developmental abnormalities by inducing trophoblastic apoptosis via the calpain1-AIF pathway.n “,”Objective::Structural abnormalities and dysfunction of the placenta contribute to pregnancy-related complications, such as preeclampsia. Syncytin-A (synA) has been reported to be expressed in the placenta. The contribution of synA to developmental abnormalities and dysfunction of the placenta remains elusive. In this study, we aimed to explore the role of synA in placental development and functions.Methods::SynA-knockout mice were generated using the CRISPR-Cas9 method, and the phenotypes of the placenta and fetus of n synA-knockout mice were observed. Real-time quantitative polymerase chain reaction (PCR) and routine PCR were employed to detect the genotypes of the offspring. CD31 immunohistochemistry was used to evaluate the vessel density of the placenta, and the protein levels of key molecules were measured by western blotting.n Results::SynA knockout caused fetal death. Furthermore, n synA-knockout mice showed placental developmental abnormalities, indicated by a thinner labyrinth layer, thicker spongiotrophoblast layer, lower blood vessel density, and significantly higher numbers of apoptotic trophoblasts, when compared with wild-type littermates. Mechanistically, n synA ablation induced apoptosis-inducing factor (AIF) cleavage and nuclear localization and promoted placental trophoblast apoptosis. In addition, n synA knockout increased the calpain1 protein levels. The calpain1 inhibitor calpeptin blocked n synA knockout-induced AIF cleavage, partially restoring the placental structural abnormalities of n synA-knockout mice.n Conclusions::SynA knockout leads to placental developmental abnormalities by inducing trophoblastic apoptosis via the calpain1-AIF pathway.n
其他文献
目的探讨舒血宁注射液联合依达拉奉对急性脑梗死(ACI)患者白细胞介素-6、肿瘤坏死因子-a水平的影响。方法采集收治的76例ACI患者的临床资料,将采用依达拉奉治疗的38例患者纳入对照组,将采用舒血宁注射液+依达拉奉治疗的38例患者纳入观察组。比较两组疗效、治疗前后血清白细胞介素-6(IL-6)、肿瘤坏死因子-a(TNF-a)水平及神经功能缺损程度[采用美国国立卫生院卒中量表(NIHSS)评分]。结果观察组治疗总有效率(97.37%)高于对照组(76.32%),差异有统计学意义(P<0.05);两组治
目的检索并总结冠状动脉介入患者围手术期水化预防对比剂急性肾损伤(CIAKI)的相关证据,为临床护理人员制订个性化围手术期水化方案,预防CIAKI提供循证依据。方法应用循证护理的方法,检索UpToDate、美国指南网(NGC)、欧洲心脏病学会(ESC)、JBI证据总结数据库、Cochrane数据库、PubMed、万方数据库、CNKI和中国生物医学文献数据库(CBM)中关于冠状动脉介入患者围手术期水化
目的探讨伙伴式健康宣教在初产妇中的应用效果。方法采用便利抽样法,选取2019年1月—2020年9月在上海健康医学院附属嘉定区中心医院产科分娩的124名初产妇作为研究对象。将2019年1—12月住院的62名产妇设为对照组,将2020年1—9月住院的62名产妇设为观察组。对照组采用常规健康宣教模式,观察组在对照组的基础上采用伙伴式健康教育模式。采用心理弹性量表(Connor-Davidson Resi
目的探讨新活素联合托拉塞米治疗难治性心衰的临床疗效。方法选取2016年1月~2020年7月我院内科收治住院的难治性心力衰竭患者56例,按照随机数字法分为对照组和观察组各28例。对照组予托拉塞米利尿等常规抗心衰治疗,观察组在常规治疗基础上予新活素联合托拉塞米治疗。观察治疗前后心率、血压、尿量情况,观察左室舒张末内径(LVDd)、N末端血清脑钠肽原(NT-proBNP)、左心室射血分数(LVEF)、六分钟步行实验变化情况,及不良反应发生情况。结果治疗前,两组患者的心率、血压、尿量情况比较,差异无统计学意义(P
目的探讨康复新液辅助治疗对疱疹性口腔炎患儿临床症状及血清高敏C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)水平的影响。方法选取收治的疱疹性口腔炎患儿56例,随机分为对照组与研究组各28例,对照组使用常规治疗,研究组在对照组基础上使用康复新液辅助治疗,比较两组疗效,观察比较两组体温恢复、疼痛消失、疱疹消失与恢复进食水时间,比较治疗前后两组血清hs-CRP、TNF-α水平,观察两组治疗期间不良反应情况。结果研究组治疗总有效率高于对照组;研究组体温恢复、疼痛消失、疱疹消失与恢复进食水时间均明显低于对
目的观察丙种球蛋白辅助治疗新生儿肺炎的临床疗效及对免疫功能的影响。方法选取2018年6月~2019年6月我院收治的82例新生儿肺炎患者,随机分为观察组和对照组各41例。观察组采用丙种球蛋白辅助治疗,对照组采用常规疗法。对比两组疗效。结果治疗后,观察组IgA、IgG、IgM、CD4、CD3、CD4/CD8等指标均大于对照组,IL6、TNFα等指标均小于对照组,差异有统计学意义(P<0.05);观察组患儿咳嗽消失、呼吸困难改善及退热所耗时间均短于对照组(P<0.05)。观察组总有效率显著高于对照组
目的观察布地奈德联合氨溴索对新生儿肺炎患儿血气分析指标及炎症状态的影响。方法选取2018年6月~2020年6月于我院就诊的新生儿肺炎患儿80例,依随机数字表法分为观察组和对照组各40例。对照组采用氨溴索治疗,观察组于对照组基础上联用布地奈德治疗。治疗7d后比较两组血气分析指标[血氧分压(PaO2)、二氧化碳分压(PaCO2)、血氧饱和度]、血炎性因子[C反应蛋白(CRP)、降钙素原(PCT)]水平及临床症状(肺部啰音、咳嗽)消失时间和住院时间。结果治疗7d后,两组PaO2和血氧饱和度
目的探讨国内外主动呼吸循环技术的研究现况和相关文献的研究热点。方法在CNKI、万方数据库、维普以及中国生物医学数据库中检索建库至2020年10月11日的中文文献,分析文献的发表年份、地区、机构、作者数、基金支持、研究类型及内容等;在Web of Science的核心合集中进行SCI文献检索,利用CiteSpace软件对文献关键词进行可视化分析。结果共纳入中文文献52篇,2015—2020年发文量总
目的 观察地屈孕酮片联合盐酸利托君在孕28~34周先兆早产患者中的应用效果.方法 前瞻性选取2019年1月~2020年8月再我院治疗的60例先兆早产患者,采用掷硬币法分为对照组和联合组
目的探究布地奈德福莫特罗粉吸入剂与噻托溴铵(TB)用于慢阻肺急性加重期(AECOPD)的应用效果,为后续治疗AECOPD提供指导。方法选取2018年5月~2020年5月于我院就诊的AECOPD患者80例,将采用TB治疗的40例患者资料纳入对照组,将采用布地奈德福莫特罗粉吸入剂+TB治疗的40例患者资料纳入观察组。对比两组治疗前、治疗4个月后肺功能[最高呼气流速(PEF)、第一秒用力呼吸容积(FEV1)]及炎症因子[血清合肽素(Copeptin)及降钙素原(PCT)]情况。结果治疗4个月后,两组FEV1、P